Method of Generating Induced Pluripotent Stem Cells
Longevity Technology - 10-Dec-2019New reprogramming technology could provide an alternate source of material needed for therapies
Michael D. West
Dr Michael D West is the founder and CEO of AgeX Therapeutics
Michael D. West is a gerontologist, and a pioneer in stem cells, cellular aging and telomerase. He is the founder and CEO of AgeX Therapeutics, a startup focused on the field of interventional gerontology, and Co-CEO of its parent company, BioTime, Inc.
Visit website: https://en.wikipedia.org/wiki/Michael_D._West
See also: 
AgeX Therapeutics
- Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease
Details last updated 02-Oct-2019
Michael D. West is also referenced in the following:
Healthy Masters International Conference
05-Nov-2022 to 06-Nov-2022
Healthy Masters conference about living longer and healthier life
Longevity Summit Dublin 2022
18-Sep-2022 to 20-Sep-2022
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Michael D. West News
LEAF interviews AgeX Therapeutics CEO Dr. Michael West
Lifespan.io (LEAF) - 30-Sep-2019May only be a few years away from implementing induced tissue regeneration in humans
Michael West examines how to safely revive telomerase
Lifespan.io (LEAF) - 12-Sep-2019It powers foetal development and telomere length, but also cancers
AgeX Identifies Genes Implicated in Regeneration and Cancer
Business Wire - 02-Jan-2018Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...
BioTime's CEO: Human Aging Will Soon Become a Thing of the Past
Mauldin Economics - 06-Jun-2017Cells become dysfunctional or die with aging. Now able to manufacturer any of the cellular build...
